Literature DB >> 14530223

Angiotensin AT2 receptors: cardiovascular hope or hype?

Robert E Widdop1, Emma S Jones, Ruth E Hannan, Tracey A Gaspari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14530223      PMCID： PMC1574085          DOI： 10.1038/sj.bjp.0705448

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  193 in total

1.  Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats.

Authors:  Christiane Pees; Thomas Unger; Peter Gohlke
Journal:  Int J Biochem Cell Biol       Date:  2003-06       Impact factor: 5.085

2.  Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling.

Authors:  Yoshihiko Oishi; Ryoji Ozono; Yoko Yano; Yasuhiro Teranishi; Masahiro Akishita; Masatsugu Horiuchi; Tetsuya Oshima; Masayuki Kambe
Journal:  Hypertension       Date:  2002-12-23       Impact factor: 10.190

3.  Localization of AT(2) receptors in the nucleus of the solitary tract of spontaneously hypertensive and Wistar Kyoto rats using [125I] CGP42112: upregulation of a non-angiotensin II binding site following unilateral nodose ganglionectomy.

Authors:  Carli L Roulston; Andrew J Lawrence; Bevyn Jarrott; Robert E Widdop
Journal:  Brain Res       Date:  2003-04-04       Impact factor: 3.252

4.  Disparate roles of AT2 receptors in the renal cortical and medullary circulations of anesthetized rabbits.

Authors:  Lisa M Duke; Gabriela A Eppel; Robert E Widdop; Roger G Evans
Journal:  Hypertension       Date:  2003-07-07       Impact factor: 10.190

5.  AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR.

Authors:  Xiao C Li; Robert E Widdop
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

6.  Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells.

Authors:  Yi Zhao; Torsten Biermann; Claudia Luther; Thomas Unger; Juraj Culman; Peter Gohlke
Journal:  J Neurochem       Date:  2003-05       Impact factor: 5.372

7.  Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis.

Authors:  Satoshi Kurisu; Ryoji Ozono; Tetsuya Oshima; Masayuki Kambe; Takafumi Ishida; Hiroshi Sugino; Hideo Matsuura; Kazuaki Chayama; Yasuhiro Teranishi; Osamu Iba; Katsuya Amano; Hiroaki Matsubara
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

8.  Differential regulation by AT(1) and AT(2) receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aorta.

Authors:  Ruth E Hannan; Tracey A Gaspari; Elizabeth A Davis; Robert E Widdop
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

9.  Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury.

Authors:  Zemin Cao; Fabrice Bonnet; Riccardo Candido; Stefan P Nesteroff; Wendy C Burns; Hiroshi Kawachi; Fujio Shimizu; Robert M Carey; Marc De Gasparo; Mark E Cooper
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

10.  Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide.

Authors:  Ruth E Hannan; Elizabeth A Davis; Robert E Widdop
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739
View more
  62 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies.

Authors:  Atsushi Miyamoto; Ryoko Wada; Aya Inoue; Shigeru Ishiguro; James K Liao; Akira Nishio
Journal:  Life Sci       Date:  2005-10-11       Impact factor: 5.037

3.  High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats.

Authors:  Dong You; Laurent Loufrani; Celine Baron; Bernard I Levy; Robert E Widdop; Daniel Henrion
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

Review 4.  Update on the angiotensin AT(2) receptor.

Authors:  Claudia A McCarthy; Robert E Widdop; Kate M Denton; Emma S Jones
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

5.  Association of polymorphisms in angiotensin II receptor genes with aldosterone-producing adenoma.

Authors:  Jinzhi Ouyang; Zhun Wu; Jinchun Xing; Yongji Yan; Guoxi Zhang; Baojun Wang; Hongzhao Li; Xin Ma; Xu Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

6.  AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation.

Authors:  Joep H M van Esch; Martin P Schuijt; Jilani Sayed; Yawar Choudhry; Thomas Walther; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

Review 7.  The protective arms of the renin-angiontensin system in stroke.

Authors:  Claudia A McCarthy; Lachlan J Facey; Robert E Widdop
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

8.  Tissue inhibitor of metalloproteinase-1 and -3 improves cardiac function in an ischemic cardiomyopathy model rat.

Authors:  Ayako Uchinaka; Naomasa Kawaguchi; Seiji Mori; Yoshinosuke Hamada; Shigeru Miyagawa; Atsuhiro Saito; Yoshiki Sawa; Nariaki Matsuura
Journal:  Tissue Eng Part A       Date:  2014-06-16       Impact factor: 3.845

9.  AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR.

Authors:  Xiao C Li; Robert E Widdop
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

Review 10.  Candesartan in heart failure.

Authors:  Toni L Ripley; Jennifer S Chonlahan; Robin E Germany
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.